| Literature DB >> 30341122 |
Sanna Toppila-Salmi1,2, Heikki Rihkanen3, Martti Arffman4, Kristiina Manderbacka4, Ilmo Keskimaki4, Maija L Hytönen3.
Abstract
OBJECTIVES: Endoscopic sinus surgery (ESS) is a common operation typically performed due to chronic rhinosinusitis (CRS). There are limited data on the nationwide ESS rate and factors contributing to its regional variation. The aim was to evaluate factors causing variation of ESS rate.Entities:
Keywords: chronic rhinosinusitis; ginusitis; nasal polyps; register; surgery
Mesh:
Year: 2018 PMID: 30341122 PMCID: PMC6196818 DOI: 10.1136/bmjopen-2018-022173
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Figure 1Age distribution of endoscopic sinus surgery (ESS) in Finland. Included are patients operated on during 2013–2015, presented as annual averages.
Figure 2Age-standardised and gender-standardised rate of endoscopic sinus surgery (ESS) by hospital districts in Finland (mean of the years 2013–2015). Darker colours represent higher operation rates. The circle indicates the site of the central hospital, and the size represents the number of inhabitants within the district. Districts with white circles have a medical faculty.
Factors affecting ESS rates in men and women in an adjusted Poisson regression model
| Variable | Men | Women | ||
| Null model | Adjusted model | Null model | Adjusted model | |
| RR (95% CI) | RR (95% CI) | RR (95% CI) | RR (95% CI) | |
| Age (years) | ||||
| 15–24 | 1.29 (1.11 to 1.51) | 1.16 (0.96 to 1.39) | 2.72 (2.39 to 3.11) | 2.71 (2.31 to 3.18) |
| 25–34 | 1.79 (1.55 to 2.06) | 1.68 (1.45 to 1.95) | 3.87 (3.41 to 4.39) | 3.87 (3.38 to 4.42) |
| 35–39 | 2.59 (2.23 to 3.02) | 2.40 (2.05 to 2.81) | 4.65 (4.06 to 5.32) | 4.63 (4.00 to 5.36) |
| 40–44 | 2.57 (2.20 to 3.00) | 2.48 (2.12 to 2.90) | 4.80 (4.19 to 5.50) | 4.76 (4.13 to 5.49) |
| 45–49 | 2.49 (2.14 to 2.90) | 2.35 (2.01 to 2.75) | 3.77 (3.28 to 4.34) | 3.73 (3.24 to 4.29) |
| 50–54 | 2.40 (2.06 to 2.80) | 2.24 (1.91 to 2.63) | 3.60 (3.13 to 4.14) | 3.56 (3.09 to 4.10) |
| 55–59 | 2.23 (1.90 to 2.60) | 2.06 (1.75 to 2.42) | 3.72 (3.24 to 4.27) | 3.69 (3.21 to 4.25) |
| 60–64 | 1.99 (1.69 to 2.33) | 1.88 (1.59 to 2.23) | 2.48 (2.14 to 2.88) | 2.46 (2.11 to 2.86) |
| 65–69 | 1.74 (1.48 to 2.06) | 1.72 (1.46 to 2.04) | 1.92 (1.63 to 2.25) | 1.90 (1.62 to 2.23) |
| 70+ | 1.00 | 1.00 | 1.00 | 1.00 |
| % private ORL | 2.24 (1.49 to 3.38) | 1.22 (0.74 to 2.01) | ||
| % CRSsNP | 0.73 (0.42 to 1.30) | 1.00 (0.56 to 1.76) | ||
| % CRSwNP | 0.96 (0.56 to 1.66) | 1.27 (0.67 to 2.42) | ||
| % outside HD | 0.49 (0.30 to 0.81) | 0.89 (0.49 to 1.64) | ||
| Physician density | 1.11 (0.99 to 1.25) | 1.16 (1.02 to 1.33) | ||
| HD (Var(SE)) | 0.1299 (0.0464) | 0.0751 (0.0287) | 0.1303 (0.0463) | 0.1012 (0.0381) |
CRSsNP, chronic rhinosinusitis without nasal polyps; CRSwNP, chronic rhinosinusitis with nasal polyps; ESS, endoscopic sinus surgery; HD, home district; ORL, otorhinolaryngologist operation; RR, risk ratio.